Dineo Khabele

BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer

Sergey Karakashev, Hengrui Zhu, Yuhki Yokoyama et al. · Cell Reports · 2017 · 174 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer

Andrew J. Wilson, Matthew C. Stubbs, Phillip Liu et al. · Gynecologic Oncology · 2018 · 116 citations · Full text

Medicine, Oncology, Pharmacology +17

Keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells

Deok‐Soo Son, Angelika K. Parl, Valerie Montgomery Rice et al. · Cancer Biology & Therapy · 2007 · 101 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: Implications for therapy

Dineo Khabele, Deok-Soo Son, Angelika K. Parl et al. · Cancer Biology & Therapy · 2007 · 97 citations

Medicine, Oncology, Pharmacology +9

The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium

Oluwole Fadare, Katja Gwin, Mohamed Mokhtar Desouki et al. · Modern Pathology · 2013 · 92 citations · Full text

Medicine, Oncology, Pathology +11